Bulk Manufacturer of Controlled Substances Application: VICI Health Sciences, LLC, 46185 [2023-15279]
Download as PDF
<![CDATA[
46185
Federal Register / Vol. 88, No. 137 / Wednesday, July 19, 2023 / Notices
service for any party/parties without a
method of electronic service noted on
the attached Certificate of Service and
shall file proof of service on the
Electronic Document Information
System (EDIS).
The Commission vote for this
determination took place on July 13,
2023.
The authority for the Commission’s
determination is contained in section
337 of the Tariff Act of 1930, as
amended (19 U.S.C. 1337), and in part
210 of the Commission’s Rules of
Practice and Procedure (19 CFR part
210).
By order of the Commission.
Issued: July 13, 2023.
Lisa Barton,
Secretary to the Commission.
[FR Doc. 2023–15235 Filed 7–18–23; 8:45 am]
BILLING CODE 7020–02–P
DEPARTMENT OF JUSTICE
[Docket No. DEA–1230]
Bulk Manufacturer of Controlled
Substances Application: VICI Health
Sciences, LLC
Drug Enforcement
Administration, Justice.
ACTION: Notice of application.
AGENCY:
VICI Health Sciences, LLC has
applied to be registered as a bulk
manufacturer of basic class(es) of
controlled substance(s). Refer to
SUPPLEMENTARY INFORMATION listed
below for further drug information.
DATES: Registered bulk manufacturers of
the affected basic class(es), and
applicants therefore, may submit
electronic comments on or objections to
the issuance of the proposed registration
on or before September 18, 2023. Such
persons may also file a written request
for a hearing on the application on or
before September 18, 2023.
ADDRESSES: The Drug Enforcement
Administration requires that all
SUMMARY:
comments be submitted electronically
through the Federal eRulemaking Portal,
which provides the ability to type short
comments directly into the comment
field on the web page or attach a file for
lengthier comments. Please go to
https://www.regulations.gov and follow
the online instructions at that site for
submitting comments. Upon submission
of your comment, you will receive a
Comment Tracking Number. Please be
aware that submitted comments are not
instantaneously available for public
view on https://www.regulations.gov. If
you have received a Comment Tracking
Number, your comment has been
successfully submitted and there is no
need to resubmit the same comment.
In
accordance with 21 CFR 1301.33(a), this
is notice that on May 12, 2023, VICI
Health Sciences, LLC, 6655 Amberton
Drive, Suite O, Elkridge, Maryland
21075, applied to be registered as a bulk
manufacturer of the following basic
class(es) of controlled substance(s):
SUPPLEMENTARY INFORMATION:
Controlled substance
Drug code
Ibogaine ...........................................................................................................................................................................
Fentanyl related-compounds as defined in 21 CFR 1308.11(h) .....................................................................................
The company plans to bulk
manufacture the listed controlled
substances or their intermediates for
sale to its customers. No other activities
for these drug codes are authorized for
this registration.
Claude Redd,
Acting Deputy Assistant Administrator.
[FR Doc. 2023–15279 Filed 7–18–23; 8:45 am]
BILLING CODE P
DEPARTMENT OF JUSTICE
ddrumheller on DSK120RN23PROD with NOTICES1
Notice of Lodging of Proposed Second
Amendment to Consent Decree Under
CERCLA
On July 12, 2023, the Department of
Justice lodged a proposed Second
Amendment To Consent Decree with
the United States District Court for the
Northern District of New York in the
lawsuit entitled United States of
America v. Boise Cascade Corporation,
et al., Civil Case No. 97–cv–1704 (TJM).
The proposed Second Amendment To
Consent Decree is intended to modify
the Consent Decree entered by the Court
on February 20, 1998, as amended by
the First Amendment To Consent
Decree, entered by the Court on June 7,
2005. The Complaint in this matter was
filed on November 20, 1997. Under the
VerDate Sep<11>2014
00:36 Jul 19, 2023
Jkt 259001
Consent Decree, as amended in 2005,
Settling Defendants are required to
perform remedial work at the Sealand
Superfund Restoration Site (‘‘the Site’’)
located in Lisbon, New York and to
reimburse the Environmental Protection
Agency’s response costs pertaining to
this Site in accordance with the
requirements of the Comprehensive
Environmental Response, Compensation
and Liability Act (‘‘CERCLA’’), 42 U.S.C.
9601–9675. One of the Settling
Defendants, SBC Holdings Inc. (‘‘SBC’’),
now lacks the financial capability to
continue these obligations. The
proposed Second Amendment To
Consent Decree includes an ability-topay-cash-out settlement with SBC in
which it will pay $150,000 and removes
SBC as a Settling Defendant responsible
for future work and costs at the Site.
The remaining Settling Defendants have
agreed to the proposed Second
Amendment and will continue to be
jointly and severally liable for all work
and costs at the Site.
The publication of this notice opens
a period for public comment on the
Consent Decree. Comments should be
addressed to the Assistant Attorney
General, Environment and Natural
Resources Division, and should refer to
United States of America v. Boise
Cascade Corporation, et al., Civil Case
PO 00000
Frm 00059
Fmt 4703
Sfmt 4703
7260
9850
Schedule
I
I
No. 97–cv–1704 (TJM), D.J. Ref. No. 90–
11–3–1144/1. All comments must be
submitted no later than thirty (30) days
after the publication date of this notice.
Comments may be submitted either by
email or by mail:
To submit
comments:
Send them to:
By email .......
pubcomment-ees.enrd@
usdoj.gov.
Assistant Attorney General,
U.S. DOJ—ENRD,
P.O. Box 7611,
Washington, DC 20044–7611.
By mail .........
During the public comment period,
the Consent Decree may be examined
and downloaded at this Justice
Department website: https://
www.justice.gov/enrd/consent-decrees.
We will provide a paper copy of the
Consent Decree upon written request
and payment of reproduction costs.
Please mail your request for a paper
copy and payment to: Consent Decree
Library, U.S. DOJ—ENRD, P.O. Box
7611, Washington, DC 20044–7611.
Please enclose a check or money order
for $5.75 (25 cents per page
E:\FR\FM\19JYN1.SGM
19JYN1
]]>Agencies
[Federal Register Volume 88, Number 137 (Wednesday, July 19, 2023)]
[Notices]
[Page 46185]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-15279]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
[Docket No. DEA-1230]
Bulk Manufacturer of Controlled Substances Application: VICI
Health Sciences, LLC
AGENCY: Drug Enforcement Administration, Justice.
ACTION: Notice of application.
-----------------------------------------------------------------------
SUMMARY: VICI Health Sciences, LLC has applied to be registered as a
bulk manufacturer of basic class(es) of controlled substance(s). Refer
to SUPPLEMENTARY INFORMATION listed below for further drug information.
DATES: Registered bulk manufacturers of the affected basic class(es),
and applicants therefore, may submit electronic comments on or
objections to the issuance of the proposed registration on or before
September 18, 2023. Such persons may also file a written request for a
hearing on the application on or before September 18, 2023.
ADDRESSES: The Drug Enforcement Administration requires that all
comments be submitted electronically through the Federal eRulemaking
Portal, which provides the ability to type short comments directly into
the comment field on the web page or attach a file for lengthier
comments. Please go to https://www.regulations.gov and follow the
online instructions at that site for submitting comments. Upon
submission of your comment, you will receive a Comment Tracking Number.
Please be aware that submitted comments are not instantaneously
available for public view on https://www.regulations.gov. If you have
received a Comment Tracking Number, your comment has been successfully
submitted and there is no need to resubmit the same comment.
SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.33(a), this
is notice that on May 12, 2023, VICI Health Sciences, LLC, 6655
Amberton Drive, Suite O, Elkridge, Maryland 21075, applied to be
registered as a bulk manufacturer of the following basic class(es) of
controlled substance(s):
------------------------------------------------------------------------
Controlled substance Drug code Schedule
------------------------------------------------------------------------
Ibogaine........................... 7260 I
Fentanyl related-compounds as 9850 I
defined in 21 CFR 1308.11(h).
------------------------------------------------------------------------
The company plans to bulk manufacture the listed controlled
substances or their intermediates for sale to its customers. No other
activities for these drug codes are authorized for this registration.
Claude Redd,
Acting Deputy Assistant Administrator.
[FR Doc. 2023-15279 Filed 7-18-23; 8:45 am]
BILLING CODE P
